SEC SCHEDULE 13G

Company

Syndax Pharmaceuticals Inc

Filed

January 10, 2023

Accession Number

0000902219-23-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →